Skip to main content
. 2017 Mar 23;18(2):95–99. doi: 10.1038/gene.2017.6

Table 1. Characteristics of the admixture mapping population.

Characteristic Cases (N=389) Controls (N=175) P-value
Age (years), n (%)     0.051
 10–19 3 (0.77%) 0 (0.00%)  
 20–29 23 (5.91%) 15 (8.57%)  
 30–39 30 (7.71%) 18 (10.29%)  
 40–49 65 (16.71%) 23 (13.14%)  
 50–59 112 (28.79%) 35 (20.00%)  
 60–69 90 (23.14%) 44 (25.14%)  
 70–79 46 (11.83%) 26 (14.86%)  
 80–89 15 (3.86%) 14 (8.00%)  
 >89 5 (1.29%) 0 (0.00%)  
Gender, n (%)     0.491
 Female 199 (51.16%) 95 (54.29%)  
 Male 190 (48.84%) 80 (45.71%)  
Injection drug use, n (%)     0.177
 No 362 (95.77%) 142 (98.61%)  
 Yes 16 (4.23%) 2 (1.39%)  
Diabetic, n (%)     0.001
 No 195 (51.59%) 116 (66.29%)  
 Yes 183 (48.41%) 59 (33.71%)  
Hemodialysis dependence, n (%)     <0.001
 No 218 (57.67%) 165 (94.29%)  
 Yes 160 (42.33%) 10 (5.71%)  
Neoplasm, n (%)     <0.001
 No 338 (89.42%) 134 (76.57%)  
 Yes 40 (10.58%) 41 (23.43%)  
Rheumatoid arthritis, n (%)     0.477
 No 369 (98.40%) 142 (97.26%)  
 Yes 6 (1.60%) 4 (2.74%)  
Corticosteroid use past 30 days, n (%)     0.207
 No 303 (80.16%) 124 (84.93%)  
 Yes 75 (19.84%) 22 (15.07%)  
Surgery past 30 days, n (%)     <0.001
 No 299 (79.31%) 112 (64.00%)  
 Yes 78 (20.69%) 63 (36.00%)  
Permanently implanted foreign body, n (%)     0.354
 No 128 (34.04%) 56 (38.36%)  
 Yes 248 (65.96%) 90 (61.64%)  

The denominator for each summary is the number of non-missing values for the respective characteristic.